MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL. [electronic resource]
Producer: 20150511Description: 834-44 p. digitalISSN:- 1551-4005
- Antineoplastic Agents -- pharmacology
- Cell Fusion
- Cell Line, Tumor
- Cell Proliferation
- Cyclin-Dependent Kinase 6 -- genetics
- Enhancer of Zeste Homolog 2 Protein
- G1 Phase -- drug effects
- Humans
- Infant
- Myeloid-Lymphoid Leukemia Protein -- genetics
- Oncogene Proteins, Fusion -- genetics
- Piperazines -- pharmacology
- Polycomb Repressive Complex 2 -- genetics
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- metabolism
- Pyridines -- pharmacology
- Salivary Proline-Rich Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.